1 option
Denosumab (Prolia) : treatment to increase bone mass in men with osteoporosis at high risk for fracture, or who have failed or are intolerant to other available osteoporosis therapy / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author.
- Series:
- Common drug review clinical review report.
- Common drug review clinical review report
- Language:
- English
- Subjects (All):
- Osteoporosis--Prevention.
- Osteoporosis.
- Physical Description:
- 1 online resource. : illustrations.
- Other Title:
- Denosumab
- Place of Publication:
- Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2015.
- Notes:
- Description based on: online resource; title from PDF information screen (NCBI, viewed November 02, 2022).
- Includes bibliographical references.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.